Rapid improvement of life-threatening capillary leak syndrome after stem cell transplantation by bevacizumab

Blood

Volumn 115, Issue 13, 2010, Pages 2723-2724

  Yabe, Hiromasa ^a   Yabe, Miharu ^a   Koike, Takashi ^a   Shimizu, Takashi ^a   Morimoto, Tsuyoshi ^a   Kato, Shunichi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BEVACIZUMAB; PREDNISOLONE; ULINASTATIN;

ANURIA; ASCITES; BRAIN DISEASE; CAPILLARY LEAK SYNDROME; CASE REPORT; CENTRAL VENOUS PRESSURE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; EDEMA; FANCONI ANEMIA; GRAFT VERSUS HOST REACTION; HUMAN; HYPOTENSION; INFORMED CONSENT; LETTER; MALE; PLEURA EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TACHYCARDIA; TACHYPNEA;

EID: 77950971670     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-11-247056     Document Type: Letter

References (5)

1. Nürnberger W, Willers R, Burdach S, et al. Risk factor for capillary leak syndrome after bone marrow transplantation. Ann Hematol. 1997;74(5):221-224. (Pubitemid 27230687)
2. Grove CS, Lee YC. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med. 2002;8(4):294-301. (Pubitemid 34625963)
3. Pichelmayer O, Zielinski C, Raderer M. Response of a nonmalignant pleural effusion to bevacizumab. N Engl J Med. 2005;353(7):740-741. (Pubitemid 41175690)
4. Yabe H, Inoue H, Matsumoto M, et al. Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia. Br J Haematol. 2006;134(2):208-212.
5. Woywodt A, Haubitz M, Buchholz S et al. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;34(12):1015-1023. (Pubitemid 40028832)